The Cytomorphological Spectrum of Mantle Cell Lymphoma is Reflected by Distinct Biological Features

References

• Banks P. M., Chan J., Cleary M. L., Delsol G., De Wolf-Peeters C., Gatter K., Grogan T. M., Harris N. L., Isaacson P. G., Jaffe E. S., Mason D., Pileri S., Ralfkiaer E., Stein H., Warnke R. A. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16: 637–640
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., De Wolf-Peeters C, Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Müller-Hermelink H.-K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Gerard-Marchant R., Hamlin I., Lennert K., Rilke F., Stansfeld A. G., Van Unnik J. A.M. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 406–408
   Web of Science ®Google Scholar
• Stein H., Lennert K., Feller A. C., Mason D. Y. Immunohistochemical analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res 1984; 42: 67–147
   PubMed Web of Science ®Google Scholar
• Hummel M., Tamaru J., Kalvelage B., Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403–407
   PubMed Web of Science ®Google Scholar
• Lennert K., Mohri N. Histopathology and diagnosis of non-Hodgkin's lymphomas. Lymphomas of germinal-center cells. Malignant lymphomas other than Hodgkin's disease, K Lennert. Springer, Berlin Heidelberg New York 1978; 281–345
   Google Scholar
• Jaffe E. S., Bookman M. A., Longo D. L. Lymphocytic lymphoma of intermediate differentiation-mantle zone lymphoma: A distinct subtype of B-cell lymphoma. Hum Pathol 1987; 18: 877–880
   PubMed Web of Science ®Google Scholar
• J Lardelli P., Bookman M. A., Sundeen J., Longo D. L., Jaffe E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunologic spectrum and clinical correlations. Am J Surg Pathol 1990; 14: 752–763
   PubMed Web of Science ®Google Scholar
• Zoldan M. C., Inghirami G., Masuda Y, Vandekerckhove F., Raphael B., Amorosi E., Hymes K., Frizzera G. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol 1996; 93: 475–486
   PubMed Web of Science ®Google Scholar
• Ott G., Kalla J., Ott M. M., Schryen B., Katzenberger T., Müller J. G., Müller-Hermelink H. K. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the MTC region and tetraploid chromosome clones. Blood 1997; 89: 1421–1429
   PubMed Web of Science ®Google Scholar
• Plank L., Hansmann M.-L., Lennert K. Centrocytic lymphoma. Am J Surg Pathol 1993; 17: 638–639, [letter]
   PubMed Web of Science ®Google Scholar
• Ott M. M., Ott G., Kuse R., Porowski P., Gunzer U., Feller A. C., Müller-Hermelink H. K. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 1994; 24: 329–334
   PubMed Web of Science ®Google Scholar
• Lennert K. The proposal for a Revised European American Lymphoma classification - a new start of a transatlantic discussion. Histopathology 1995; 26: 481–483
   PubMed Web of Science ®Google Scholar
• Lennert K., Feller A. C. Histopathology of non-Hodgkin's lymphomas. Springer, New York, Berlin, Heidelberg 1992
   Google Scholar
• Kreipe H., Wacker H. H., Heidebrecht H. J., Haas K., Hauberg M., Tiemann M., Parwaresch R. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 1993; 142: 1689–1694
   PubMed Web of Science ®Google Scholar
• Zukerberg L., Medeiros L., Ferry J., Harris N. L. Diffuse low-grade B-cell lymphomas: Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993; 100: 373–385
   PubMed Web of Science ®Google Scholar
• Bosch F, Lopez-Guillermo A., Campo E., Ribera J. M., Conde E., Piris M. A., Vallespi T., Woessner S., Montser-Rat E. Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors. Cancer 1998; 82: 567–575
   PubMed Web of Science ®Google Scholar
• Ott M. M., Helbing A., Ott G., Bartek J., Fischer L., Dürr A., Kreipe H., Müller-Hermelink H. K. Bcl-1 gene rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996; 179: 238–242
   PubMed Web of Science ®Google Scholar
• Lukas J., Pagano M., Staskova Z., Draetta G., Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994; 9: 707–718
   PubMed Web of Science ®Google Scholar
• Bartkova J., Lukas J., Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of cyclin D1 protein. J Pathol 1994; 172: 237–245
   PubMed Web of Science ®Google Scholar
• Bartkova J., Zemanova M., Bartek J. Abundance and subcellular localisation of cyclin D3 in human tumours. M J Cancer 1996; 65: 323–327
   PubMed Web of Science ®Google Scholar
• Ott M. M., Bartkova J., Bartek J., Durr A., Fischer L., Ott G., Muller-Hermelink H. K., Kreipe H. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Blood 1997; 90: 3154–3159
   PubMed Web of Science ®Google Scholar
• Yang W., Zukerberg L. R., Motokura T., Arnold A., Harris N. L. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994; 145: 86–96
   PubMed Web of Science ®Google Scholar
• De Boer C. J., Schuuring E., Dreef E., Peters G., Bartek J., Kluin P. M., Van Krieken J. H.J.M. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86: 2715–2723
   PubMed Web of Science ®Google Scholar
• Inaba T, Matsushime H., Valentine M., Roussel M. F., Sherr C. J., Look A. T. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565–574
   PubMed Web of Science ®Google Scholar
• Ando K., Ajchenbaum-Cymbalista F., Griffin J. D. Regulation of Gl/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci USA 1993; 90: 9571–9575
   PubMed Web of Science ®Google Scholar
• Wittenberg C., Sugimoto K., Reed S. I. G1 specific cyclins of S. cerevisiae: cell cycle periodicity, regulation by mating pheromone, and association with the p34 protein kinase. Cell 1990; 62: 225–237
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F, Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995; 86: 3905–3914
   PubMed Web of Science ®Google Scholar
• Mitelman F. Catalog of Chromosome Aberrations in Cancer (ed 5). Wiley-Liss, New York, NY 1994
   Google Scholar
• Schlegelberger B., Himmler A., Godde E., Grote W., Feller A. C, Lennert K. Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 1994; 83: 505–511
   PubMed Web of Science ®Google Scholar
• Daniel M. T., Tigaud I., Flexor M. A., Nogueira M. E., Berger R., Jonveaux P. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma?. Br J Haematol 1995; 90: 77–84
   PubMed Web of Science ®Google Scholar
• Quelle D. E., Ashmun R. A., Shurtleff S. A., Kato J., Bar-Sagi D., Roussel M., Sherr C. J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559–1579
   PubMed Web of Science ®Google Scholar
• Pardee A. B. G1 events and regulation of cell proliferation. Science 1989; 246: 603–608
   PubMed Web of Science ®Google Scholar
• Sander C. A., Yano T, Clark H. M., Harris C, Longo D. L., Jaffe E. S., Raffeld M. p53 mutation is associated with progression of follicular lymphomas. Blood 1993; 82: 1994–2004
   PubMed Web of Science ®Google Scholar
• Lo Coco F, Gaidano G., Loui D. C., Offit K., Chaganti R. S.K., Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289–2295
   PubMed Web of Science ®Google Scholar
• Dohner H., Fischer K., Bentz M., Hansen K., Brenner A., Cabot G., Diehl D., Schlenk R., Coy J., Stilgenbauer S., Volkmann M., Galle P. R., Poustka A., Hunstein W., Lichter P. p53 deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995; 85: 1580–1589
   PubMed Web of Science ®Google Scholar
• Tilly H., Rossi A., Stamatoullas A., Lenormand B., Big-Orgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–1049
   PubMed Web of Science ®Google Scholar
• Ichikawa A., Kinoshita T., Watanabe T., Kato H., Nagai H., Tsushita K., Saito H., Hotta T. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 1997; 337: 529–534
   PubMed Web of Science ®Google Scholar
• Hernandez L., Fest T., Cazorla M., Teruya-Feldstein J., Bosch F., Peinado M. A., Piris M. A., Montserrat E., Cardesa A., Jaffe E. S., Campo E., Raffeld M. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351–3359
   PubMed Web of Science ®Google Scholar
• Greiner T. C., Moynihan M. J., Chan W. C., Lytle D. M., Pedersen A., Anderson J. R., Weisenburger D. D. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302–4310
   PubMed Web of Science ®Google Scholar
• Louie D. C., Offit K., Jaslow R., Parsa N. Z., Murty V. V., Schluger A., Chaganti R. S. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995; 86: 2892–2899
   PubMed Web of Science ®Google Scholar
• Brittinger G. Klinik der malignen Non-Hodgkin-Lymphome, speziell der chronischen lymphatischen Leukamie. Verh Dtsch Ges Pathol 1983; 67: 494–516
   PubMedGoogle Scholar
• Fisher R. I., Dahlberg S., Nathwani B. N., Banks P. M., Miller T. P., Grogan T. M. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study. Blood 1995; 85: 1075–1082
   PubMed Web of Science ®Google Scholar
• Velders G. A., Kluin-Nelemans J. C., De Boer C. J., Hermans J., Noordijk E. M., Schuuring E., Kramer M. H., Van Deijk W. A., Rahder J. B., Kluin P. M., Van Krieken J. H. Mantle-cell lymphoma: a population-based clinical study. J Clin Oncol 1996; 14: 1269–1274
   PubMed Web of Science ®Google Scholar
• Vaandrager J. W., Schuuring E., Zwikstra E., De Boer C. J., Kleiverda K. K., Van Krieken J. H., Kluin-Nelemans H. C., Van Ommen G. J., Raap A. K., Kluin P. M. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 1996; 88: 1177–1182
   PubMed Web of Science ®Google Scholar
• Rimokh R., Berger F., Delsol G., Charrin C., Bertheas M. F., Ffrench M., Garoscio M., Felman P., Coiffier B., Bryon P. A., Rochet M., Gentilhomme O., Germain D., Magaud J. P. Rearrangement and overexpression of the Bcl-1/PRAD1 gene in intermediate lymphocytic lymphoma and in t(11q13)-bearing leukemias. Blood 1993; 81: 3063–3067
   PubMed Web of Science ®Google Scholar
• Bosch R, Jares P., Campo E., Lopez-Guillermo A., Piris M. A., Villamor N., Tassies D., Jaffe E. S., Montserrat E., Rozman C., Cardesa A. PRAD-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726–2732
   PubMed Web of Science ®Google Scholar
• Nevins J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258: 424–429
   PubMed Web of Science ®Google Scholar
• Dowdy S. F., Hinds P. W., Louie K., Reed S. I., Arnold A., Weinberg R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993; 73: 499–511
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323–330
   PubMed Web of Science ®Google Scholar
• Pinyol M., Hernandez L., Cazorla M., Balbin M., Jares P., Fernandez P L., Montserrat E., Cardesa A., Lopez-Otin C., Campo E. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997; 89: 272–280
   PubMed Web of Science ®Google Scholar
• Dreyling M. H., Bullinger L., Ott G., Stilgenbauer S., Müller-Hermelink H. K., Bentz M., Hiddemann W., Döhner H. Alterations of the cyclin D1/p16-RB pathway in mantle cell lymphoma. Cancer Res 1997; 57: 4608–4614
   PubMed Web of Science ®Google Scholar